Insider Trading Alert - RHI, LLY And GSAT Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, Nov. 14, 2014, 101 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $203.52 to $13,546,000.00.

Highlighted Stocks Traded by Insiders:

Robert Half International (RHI) - FREE Research Report

Messmer Harold M Jr, who is Chairman & CEO at Robert Half International, sold 100,000 shares at $57.33 on Nov. 14, 2014. Following this transaction, the Chairman & CEO owned 1.3 million shares meaning that the stake was reduced by 7.32% with the 100,000-share transaction.

Glass Robert W, who is Executive Vice President at Robert Half International, sold 11,899 shares at $57.19 on Nov. 14, 2014. Following this transaction, the Executive Vice President owned 366,013 shares meaning that the stake was reduced by 3.15% with the 11,899-share transaction.

The shares most recently traded at $57.54, up $0.35, or 0.61% since the insider transaction. Historical insider transactions for Robert Half International go as follows:

  • 4-Week # shares bought: 19,768
  • 4-Week # shares sold: 10,000
  • 12-Week # shares bought: 19,768
  • 12-Week # shares sold: 10,000
  • 24-Week # shares bought: 19,768
  • 24-Week # shares sold: 334,028

The average volume for Robert Half International has been 895,000 shares per day over the past 30 days. Robert Half International has a market cap of $7.8 billion and is part of the services sector and diversified services industry. Shares are up 36.7% year-to-date as of the close of trading on Friday.

Robert Half International Inc. provides staffing and risk consulting services in North America, South America, Europe, Asia, and Australia. The stock currently has a dividend yield of 1.25%. The company has a P/E ratio of 27.2. Currently, there are 8 analysts who rate Robert Half International a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RHI - FREE

TheStreet Quant Ratings rates Robert Half International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, solid stock price performance and impressive record of earnings per share growth. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Robert Half International Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Eli Lilly and (LLY) - FREE Research Report

Lilly Endowment Inc, who is 10% Owner at Eli Lilly and, sold 200,000 shares at $67.73 on Nov. 14, 2014. Following this transaction, the 10% Owner owned 131.8 million shares meaning that the stake was reduced by 0.15% with the 200,000-share transaction.

The shares most recently traded at $67.18, down $0.55, or 0.82% since the insider transaction. Historical insider transactions for Eli Lilly and go as follows:

  • 4-Week # shares bought: 17,157
  • 4-Week # shares sold: 568,500
  • 12-Week # shares bought: 17,157
  • 12-Week # shares sold: 1.4 million
  • 24-Week # shares bought: 17,157
  • 24-Week # shares sold: 2.8 million

The average volume for Eli Lilly and has been 4.0 million shares per day over the past 30 days. Eli Lilly and has a market cap of $75.4 billion and is part of the health care sector and drugs industry. Shares are up 32.02% year-to-date as of the close of trading on Friday.

Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. It operates in two segments, Human Pharmaceutical Products and Animal Health Products. The stock currently has a dividend yield of 2.9%. The company has a P/E ratio of 27.1. Currently, there are 6 analysts who rate Eli Lilly and a buy, 1 analyst rates it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LLY - FREE

TheStreet Quant Ratings rates Eli Lilly and as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Eli Lilly and Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Globalstar (GSAT) - FREE Research Report

Roberts Richard S, who is Corporate Secretary at Globalstar, bought 50,800 shares at $2.69 on Nov. 14, 2014. Following this transaction, the Corporate Secretary owned 50,800 shares meaning that the stake was boosted by 100% with the 50,800-share transaction.

McIntyre J Patrick Jr, who is Director at Globalstar, bought 40,000 shares at $2.71 on Nov. 14, 2014. Following this transaction, the Director owned 97,983 shares meaning that the stake was boosted by 68.99% with the 40,000-share transaction.

The shares most recently traded at $2.84, up $0.13, or 4.6% since the insider transaction. Historical insider transactions for Globalstar go as follows:

  • 4-Week # shares bought: 15,500
  • 4-Week # shares sold: 8,043
  • 12-Week # shares bought: 15,500
  • 12-Week # shares sold: 8,043
  • 24-Week # shares bought: 15,500
  • 24-Week # shares sold: 8,043

The average volume for Globalstar has been 6.2 million shares per day over the past 30 days. Globalstar has a market cap of $2.4 billion and is part of the technology sector and telecommunications industry. Shares are up 69.71% year-to-date as of the close of trading on Friday.

Globalstar, Inc. provides mobile voice and data communications services through satellite worldwide. Currently, there are no analysts who rate Globalstar a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on GSAT - FREE

TheStreet Quant Ratings rates Globalstar as a sell. The area that we feel has been the company's primary weakness has been its feeble growth in its earnings per share. Get the full Globalstar Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Replay: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker

Replay: Jim Cramer on the Markets, 10-Year Yield, Oil Prices and Foot Locker

Video: You Could Live in a Ritz-Carlton or St. Regis Home

Video: You Could Live in a Ritz-Carlton or St. Regis Home